NOD1: a metabolic modulator
Nucleotide-binding oligomerization domain 1 (NOD1) is an intracellular pattern recognition receptor that detects injury signals and initiates inflammatory responses and host defense. Furthermore, NOD1 serves as a metabolic mediator by influencing the metabolism of various tissues, including adipose...
Saved in:
Main Authors: | Ruobing Tang, Chunguang Xie, Xiyu Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1484829/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The known genetic variants of BRCA1, BRCA2 and NOD2 in pancreatitis and pancreatic cancer risk assessment
by: Jarosław Matykiewicz, et al.
Published: (2025-01-01) -
Endocrine and metabolic alterations in response to systemic inflammation and sepsis: a review article
by: Syed Faizan Mehdi, et al.
Published: (2025-01-01) -
ZBiotics ameliorates T2DM-induced histopathological damage in liver, kidney and adipose tissues by modulating the NOD-like receptor signaling in Wistar rats
by: Mohammed Esawie, et al.
Published: (2025-02-01) -
Population features of prevalence and clinical-diagnostic role of NOD2 gene polymorphisms associated with Crohn’s disease
by: D. A. Kuznetsova, et al.
Published: (2018-08-01) -
Incidence and risk of endocrine and metabolic abnormalities linked to PARP inhibitors in solid tumors: a meta-analysis
by: Shunlian Fu, et al.
Published: (2025-01-01)